Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 25(21): 4848-4853, 2015 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-26159481

RESUMO

A computational docking study of a series of de novo structural analogs of the highly potent, non-nitrogen containing, acetylcholinesterase inhibitor (+)-arisugacin A is presented. In direct comparison to the recently reported X-ray single-crystal structure of (+)-territrem B bound hAChE, the modeling suggests that there is a unique conformational preference for the E-ring that is responsible for the superior inhibitory activity of (+)-arisugacin A against hAChE relative to (+)-territrem B, and that substitutions on the E-ring also play an important role in the protein-ligand interaction.


Assuntos
Acetilcolinesterase/metabolismo , Inibidores da Colinesterase/farmacologia , Simulação de Acoplamento Molecular , Piranos/farmacologia , Acetilcolinesterase/química , Animais , Sítios de Ligação/efeitos dos fármacos , Inibidores da Colinesterase/química , Relação Dose-Resposta a Droga , Estrutura Molecular , Piranos/química , Estereoisomerismo , Relação Estrutura-Atividade
2.
Biochemistry ; 52(42): 7486-99, 2013 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-24040835

RESUMO

Cholinergic synaptic transmission often requires extremely rapid hydrolysis of acetylcholine by acetylcholinesterase (AChE). AChE is inactivated by organophosphates (OPs) in chemical warfare nerve agents. The resulting accumulation of acetylcholine disrupts cholinergic synaptic transmission and can lead to death. A potential long-term strategy for preventing AChE inactivation by OPs is based on evidence that OPs must pass through a peripheral site or P-site near the mouth of the AChE active site gorge before reacting with a catalytic serine in an acylation site or A-site at the base of the gorge. An ultimate goal of this strategy is to design compounds that bind tightly at or near the P-site and exclude OPs from the active site while interfering minimally with the passage of acetylcholine. However, to target the AChE P-site with ligands and potential drugs that selectively restrict access, much more information must be gathered about the structure-activity relationships of ligands that bind specifically to the P-site. We apply here an inhibitor competition assay that can correctly determine whether an AChE inhibitor binds to the P-site, the A-site, or both sites. We have used this assay to examine three uncharged, natural product inhibitors of AChE, including aflatoxin B1, dihydrotanshinone I, and territrem B. The first two of these inhibitors are predicted by the competition assay to bind selectively to the P-site, while territrem B is predicted to span both the P- and A-sites. These predictions have recently been confirmed by X-ray crystallography. Dihydrotanshinone I, with an observed binding constant (KI) of 750 nM, provides a good lead compound for the development of high-affinity, uncharged inhibitors with specificity for the P-site.


Assuntos
Acetilcolinesterase/química , Acetilcolinesterase/metabolismo , Inibidores da Colinesterase/farmacologia , Fenantrenos/farmacologia , Acetilcolina/metabolismo , Acetilcolinesterase/genética , Aflatoxina B1/farmacologia , Sítios de Ligação , Ligação Competitiva , Catálise , Domínio Catalítico , Cristalografia por Raios X , Furanos , Humanos , Hidrólise , Cinética , Modelos Químicos , Piranos/farmacologia , Quinonas , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Relação Estrutura-Atividade , Especificidade por Substrato
3.
Bioorg Med Chem Lett ; 21(9): 2687-91, 2011 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-21216144

RESUMO

A computation docking study of the highly potent, non-nitrogen containing, acetylcholinesterase inhibitor (+)-arisugacin A is presented. The model suggests that (+)-arisugacin A is a dual binding site covalent inhibitor of AChE. These findings are examined in the context of Alzheimer's disease-modifying therapeutic design. (+)-Arisugacin A's revealed mode of action is unique, and may serve as a basis for the development of AD therapeutics capable of treating the symptomatic aspects of AD, while being neuroprotective with long term efficacy.


Assuntos
Inibidores da Colinesterase/química , Simulação por Computador , Modelos Biológicos , Piranos/química , Piranos/síntese química , Doença de Alzheimer/tratamento farmacológico , Sítios de Ligação/efeitos dos fármacos , Inibidores da Colinesterase/farmacologia , Concentração Inibidora 50 , Modelos Moleculares , Estrutura Molecular , Piranos/farmacologia
4.
New J Chem ; 34(7): 1309-1316, 2010 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-20668650

RESUMO

This work describes the first examples of diastereoselective intramolecular cyclopropanations of a de novo class of push-pull carbenes derived from DMDO-epoxidations of chiral ynamides. This reaction sequence essentially constitutes a tandem epoxidation-cyclopropanation that effectively gives arise to a series of structurally unique amido-cyclopropanes. A plausible mechanistic model is proposed revealing insights into this novel cyclopropanation process.

5.
J Org Chem ; 73(22): 8780-4, 2008 Nov 21.
Artigo em Inglês | MEDLINE | ID: mdl-18937407

RESUMO

A de novo preparation of alpha-keto-imides via ynamide oxidation is described. With a number of alkyne oxidation conditions screened, a highly efficient RuO2-NaIO4 mediated oxidation and a DMDO oxidation have been identified to tolerate a wide range of ynamide types. In addition to accessing a wide variety of alpha-keto-imides, the RuO2-NaIO4 protocol provides a novel entry to the vicinal tricarbonyl motif via oxidation of push-pull ynamides, and imido acylsilanes from silyl-substituted ynamides. Chemoselective oxidation of ynamides containing olefins can be achieved by using DMDO, while the RuO2-NaIO4 protocol is not effective. These studies provide further support for the synthetic utility of ynamides.


Assuntos
Alcinos/química , Imidas/síntese química , Cetonas/química , Imidas/química , Oxirredução , Especificidade por Substrato
6.
Org Lett ; 10(4): 661-3, 2008 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-18198881

RESUMO

The reaction profile of DMDO oxidations of ynamides is described. This work illustrates the first examples of highly diastereoselective intramolecular cyclopropanations of a push-pull carbene derived from alkyne oxidation. In addition, the ynamide oxidation provides facile access to ketoimides and reveals mechanistic insights into the chemistry of electronically biased oxirenes.


Assuntos
Ciclopropanos/química , Compostos de Epóxi/química , Metano/análogos & derivados , Oxazóis/química , Hidrocarbonetos/química , Metano/química , Estrutura Molecular , Oxirredução
7.
Tetrahedron ; 64(5): 883-893, 2008 Jan 28.
Artigo em Inglês | MEDLINE | ID: mdl-19180170

RESUMO

[3 + 3] Annulations of exo-cyclic vinylogous amides and urethanes with vinyl iminium salts are described here. We observed an intriguing dichotomy in their reaction pathways. For pyrrolidine- and azepane-based vinylogous amides or urethanes, aza-[3 + 3] annulation would dominate to give tetrahydroindolizidines, whereas, unexpectedly, for piperidine-based vinylogous amides or urethanes, carbo-[3 + 3] annulation was the pathway, leading to hexahydroquinolines. The origin for such a contrast is likely associated with a switch in the initial reaction pathway between C-1,2-addition and C-1,4-addition.

8.
Org Lett ; 9(22): 4459-62, 2007 Oct 25.
Artigo em Inglês | MEDLINE | ID: mdl-17910461

RESUMO

A stereoselective halo-etherification of chiral enamides is described here. This work provides an approach to halogen containing cyclic ethers and reveals further mechanistic insights to the chemistry of chiral enamides.


Assuntos
Éteres Cíclicos/síntese química , Hidrocarbonetos Halogenados/síntese química , Modelos Moleculares , Estrutura Molecular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA